Home »
Academic Articles & Research Papers
Showing 20 of 64 academic articles
Jing Sun, Jing Wang, Xin Jiang, Jing Xia et al. • BMC Biology
(2024)
Abstract Background The intracellular bacterium Listeria monocytogenes is an attractive vector for cancer immunotherapy as it can effectively deliver tumor antigens to antigen-presenting cells, leading to a robust antitumor response. Result...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12915-024-02086-7
Patrick Leo, Hauke Kolster, Hartmut Koeppen, Jennifer Giltnane et al. • Journal of Pathology Informatics
(2026)
Whereas anti-PD-(L)1 therapies are widely used in cancer treatment, only a subset of patients achieve long-term survival. Companion diagnostics based on PD-L1 expression have limited predictive power for these therapies, motivating developm...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.jpi.2026.100688
Rui Huang, Jian-Gao Fan, Jun-Ping Shi, Yi-Min Mao et al. • Health and Quality of Life Outcomes
(2021)
Abstract Background Health Related Quality of Life (HRQL) is a multi-dimensional construct that can comprehensively evaluate the patient’s health status, including physical, emotional, mental and social well-being. In this study, we aimed t...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12955-021-01778-w
Yanshang Wang, Xiaoping Wei • BMJ Open
(2026)
Introduction Electronic patient-reported outcome (ePROs)-based symptom monitoring benefits health-related quality of life (HRQoL) in various cancers. However, despite the high disease and economic burden of hepatocellular carcinoma (HCC) an...
DOAJ
Open Access (DOAJ)
DOI: 10.1136/bmjopen-2026-116199
Ruichen Su, Tian Zhou • Frontiers in Aging Neuroscience
(2021)
Parkinson’s disease (PD) is a neurodegenerative disorder closely related to immunity. An important aspect of the pathogenesis of PD is the interaction between α-synuclein and a series of immune cells. Studies have shown that accumulation of...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnagi.2021.769506
Dr. A. Solaiappan • ACCENT JOURNAL OF ECONOMICS ECOLOGY & ENGINEERING
(2026)
Abstract: Medical biotechnology has emerged as a transformative field that integrates molecular biology, genetics, bioinformatics, nanotechnology, and biomedical engineering to improve the prevention, diagnosis, and treatment of human disea...
OPENALEX
Open Access
Dan Lu, Yuan Chen, Min Jiang, Jie Wang et al. • Nature Communications
(2023)
Abstract KRAS mutations are broadly recognized as promising targets for tumor therapy. T cell receptors (TCRs) can specifically recognize KRAS mutant neoantigens presented by human lymphocyte antigen (HLA) and mediate T cell responses to el...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41467-023-42010-1
Wei Liu, Yan Xu, Yi Wang, Lugui Qiu et al. • Journal for ImmunoTherapy of Cancer
(2024)
Background Over 50% of patients with relapsed or refractory large B-cell lymphoma (r/r LBCL) receiving CD19-targeted chimeric antigen receptor (CAR19) T-cell therapy fail to achieve durable remission. Early identification of relapse or prog...
DOAJ
Open Access (DOAJ)
DOI: 10.1136/jitc-2023-008450
Sophia Daum, Lilith Decristoforo, Mira Mousa, Stefan Salcher et al. • Molecular Cancer
(2025)
Abstract The dynamic interactions between tumor endothelial cells (TECs) and the immune microenvironment play a critical role in the progression of non-small cell lung cancer (NSCLC). In general, endothelial cells exhibit diverse immunomodu...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12943-024-02221-6
Ziqiang Wang, Jing Zhang, Huili Chen, Xinyu Zhang et al. • Frontiers in Immunology
(2025)
BackgroundM2-like tumor-associated macrophages (TAMs) promote an immunosuppressive microenvironment and contribute to tumor progression and metastasis. However, their molecular characterization and prognostic value have not been fully explo...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2025.1650726
Arias V, Clubb JH, Kudling TV, Jirovec E et al. • Journal for immunotherapy of cancer
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1136/jitc-2026-016430
PMC: PMC13735263
Akkuş AF, Bölek H, Kaplan Tüzün E, Serteşen Camöz E et al. • BMC cancer
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12885-026-16664-1
PMC: PMC13737897
• Annals of Internal Medicine
(1979)
This text and review has been updated and revised since the last edition in 1974. The normal immunologic function and disease processes are presented clearly. New features include emphasis on normal immunologic function and disease processe...
OPENALEX
DOI: https://doi.org/10.7326/0003-4819-90-4-732_3
Zhongru Fan, Dongyu Han, Xin Fan, Lin Zhao • Frontiers in Immunology
(2023)
BackgroundOvarian cancer (OC) is one of the malignant tumors that poses a serious threat to women’s health. Natural killer (NK) cells are an integral part of the immune system and have the ability to kill tumor cells directly or participate...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2023.1308143
Mark W. D. Sweep, Mark W. D. Sweep, Martijn J. H. Tjan, Mark A. J. Gorris et al. • Frontiers in Immunology
(2023)
Immune checkpoint inhibitor therapy for cancer treatment can give rise to a variety of adverse events. Here we report a male patient with metastatic melanoma who experienced life-threatening colitis and duodenitis following treatment with i...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fimmu.2023.1212432
Mario Valenti, Matteo Bianco, Alessandra Narcisi, Antonio Costanzo et al. • Dermatology Practical & Conceptual
(2024)
Actinic keratosis (AK) is a frequent precancerous skin lesion that mostly affects chronically sun-exposed areas. Chronic sun damage leads to various mutations in onco-suppressor and oncogenic genes which cause an uncontrolled proliferation ...
DOAJ
Open Access (DOAJ)
DOI: 10.5826/dpc.1403S1a145S
Liu D, Tang J, Jiang Y, Zhao J et al. • Frontiers in Immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1979117
PMC: PMC13736041
Pomej K, Frick A, Scheiner B, Baumgartner M et al. • Nature communications
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1038/s41467-026-78219-z
PMC: PMC13736962
Ismayilov R, Altundag O, Akcali Z • Immunotherapy
(2025)
PMC
PMC Public Access (View-Only)
DOI: 10.1080/1750743X.2025.2580272
PMC: PMC12607292
Mingxin Hu, Chaoxing He, Jintao Hao, Nannan Qi et al. • Journal of Translational Medicine
(2026)
Abstract Background Leukemia is a highly heterogeneous and aggressive hematological malignancy. Current therapeutic approaches (e.g. chemotherapy, radiotherapy, small-molecule targeted therapies, and hematopoietic stem cell transplantation,...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12967-026-07966-w